1,463 results match your criteria: "Hotel Dieu Hospital[Affiliation]"
EClinicalMedicine
December 2024
AP-HP Hotel-Dieu Hospital, Centre de Recherche épidémiologie et Statistiques (CRESS-UMR1153), Centre d'épidémiologie Clinique, Inserm / Université Paris Cité / AP-HP, Centre Virchow-Villermé, Centre Equator France, Paris, France.
Background: Immune checkpoint inhibitors (ICIs) have demonstrated their efficacy with a 7.5-year overall survival (OS) close to 50% for advanced stages. The design of clinical trials provides for treatment until progression or toxicity, or for a maximum duration of two years.
View Article and Find Full Text PDFAngiogenesis
December 2024
Innovative Therapies in Hemostasis, Paris Cité University, INSERM, Paris, 75006, France.
Clin Nucl Med
December 2024
Hotel Dieu Hospital, Paris-Cité University, APHP, Department of Infectious Disease, Paris, France.
Purpose: Neurological symptoms often prominent in post-acute sequelae of COVID-19 (PASC) necessitate deeper understanding. Our objective was to investigate brain metabolism in PASC and examine correlations with neurological symptoms during both the acute and chronic stages.
Methods: Eighty-seven adults experiencing PASC with neurocognitive symptoms were recruited in the PERSICOR prospective study and examined using brain [18F]FDG PET/CT.
Contact Dermatitis
December 2024
Department of Occupational and Environmental Diseases, Hotel-Dieu Hospital, AP-HP Centre - Université Paris Cité, AP-HP, Paris, France.
Arch Cardiovasc Dis
December 2024
Santé Publique France, 94410 Saint-Maurice, France.
Background: Peripheral arterial diseases (PADs) account for much of the morbidity and hospitalizations experienced by patients with cardiovascular disease. Epidemiological data on these diseases are lacking in France.
Aims: To describe the epidemiology of aortic diseases (aneurysm and dissection) and PADs in France in 2022.
Arch Cardiovasc Dis
December 2024
Santé Publique France, 94410 Saint-Maurice, France.
Background: Few epidemiological data are available for venous thromboembolism (VTE) at French national and subnational levels.
Aims: To quantify VTE events in France in 2022 and describe the features of hospital management and outcomes.
Methods: Adults hospitalized for a VTE as the primary reason for hospitalization or treatment in a medical unit in 2022 were identified from medical administrative data.
Arch Cardiovasc Dis
December 2024
Santé Publique France, 94410 Saint-Maurice, France.
Background: Elevated concentrations of low-density lipoprotein cholesterol (LDL-C) are highly prevalent and are associated with the development of cardiovascular diseases.
Aim: To estimate the proportion of cardiovascular disease cases attributable to high concentrations of LDL-C (population attributable fraction [PAF]) in France in 2017, based on the most recent individual data on LDL-C, and the attributable burden on hospitalizations and death.
Methods: We estimated the PAF of high LDL-C concentrations for ischaemic heart disease (IHD), ischaemic stroke and aortic valve stenosis (AVS).
Arch Cardiovasc Dis
December 2024
Santé Publique France, 94410 Saint-Maurice, France.
Rheumatology (Oxford)
November 2024
Department of Rheumatology and National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, Hôpital Bicêtre, Université Paris-Saclay, Le Kremlin Bicêtre, France.
Objectives: To evaluate the effectiveness of short message service (SMS) and/or email reminders in improving influenza vaccination coverage rates among rheumatoid arthritis (RA) patients treated with anti-TNF therapies, and to identify factors associated with vaccination.
Methods: A nested randomized controlled trial in the ART e-cohort, an ongoing French nationwide multicentre prospective cohort of RA patients treated with anti-TNF therapy. Patients were 1:1 randomized, with stratification on age.
Endosc Int Open
November 2024
Division of Gastroenterology, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
J Autoimmun
December 2024
Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, East and West, Assistance Publique - Hôpitaux de Paris, F-75014 Paris, France; Paris Cité University, F-75006, Paris, France. Electronic address:
Objectives: Current guidelines suggest treating poor-prognosis eosinophilic granulomatosis with polyangiitis (EGPA) with a combination of glucocorticoids (GCs) plus cyclophosphamide (CYC). However, there is little data to support the need for the addition of CYC. The objective of this study was to compare GCs plus CYC to GCs alone as induction therapy in poor-prognosis EGPA.
View Article and Find Full Text PDFArch Cardiovasc Dis
December 2024
Santé Publique France, 94410 Saint-Maurice, France.
Contact Dermatitis
November 2024
Department of Occupational and Environmental Diseases, Hotel-Dieu Hospital, APHP, Centre-Université Paris Cité, AP-HP, Paris, France.
Arch Cardiovasc Dis
December 2024
Cardiovascular and Neurovascular Disease Surveillance Unit, Santé Publique France, 94410 Saint-Maurice, France.
Surg Oncol
December 2024
Sorbonne University, Tenon Hospital, APHP, ENT and Head and Neck Surgery Department, 4 Rue de la Chine, 75020, Paris, France. Electronic address:
J Visc Surg
April 2024
Department of Digestive, Oncological, Endocrine, Hepatobiliary Surgery and Liver Transplantation, Trousseau Hospital, CHU de Tours, Tours, France.
Introduction: Curative management of retroperitoneal sarcoma relies on surgery, and complete monoblock resection is one of the main prognostic factors. The goal of this study was to search predictive factors for incomplete resection.
Methods: All patients undergoing surgery for retroperitoneal sarcoma in two University hospitals between 2010 and 202 were included.
Objective: To provide family physicians with a practical evidence-based approach to management of otitis externa.
Sources Of Information: The approach described is based on MEDLINE and PubMed literature published between 1993 and 2023.
Main Message: Otitis externa is diffuse inflammation of the external auditory canal and typically occurs from moisture exposure and trauma.
PLoS One
September 2024
URC-ECO, Hotel-Dieu Hospital, AP-HP, Paris, France.
An oral two-drug regimen (O2DR) in the form of a once-a-day single tablet is now recommended for treatment switching and treatment initiation for HIV. In clinical care, the process of treatment change refers to adaptation issues, both individual and within the care relationship. The study aim is to present the determinants involved in the acceptability of switching to O2DR in the PROBI (Patient-Reported Outcomes BItherapy) qualitative study.
View Article and Find Full Text PDFBMC Med
September 2024
Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), Paris, 75004, France.
Background: The objective of the study was to identify the psychosocial and contextual markers considered by physicians to personalize care.
Methods: An online questionnaire with one open-ended question, asking physicians to describe clinical situations in which they personalized care, was used. Physicians were recruited from March 31, 2023, to August 10, 2023, from three hospitals, five university departments of general practice and six physician organizations in France.
Arch Cardiovasc Dis
October 2024
Department of Hypertension, Université Paris Cité, AP-HP, HEGP, 75015 Paris, France.
Several high-quality, randomized, sham-controlled trials have provided evidence supporting the efficacy and safety of radiofrequency, ultrasound and alcohol catheter-based renal denervation (RDN) for reducing blood pressure (BP). A French clinical consensus document has therefore been developed to propose guidance for the appropriate use of RDN in the management of hypertension along with a dedicated care pathway and management strategy. The French experts group concluded that RDN can serve as an adjunct therapy for patients with confirmed uncontrolled, resistant essential hypertension despite treatment with≥3 antihypertensive drugs, including a long-acting calcium channel blocker, a renin-angiotensin system blocker and a thiazide/thiazide-like diuretic at maximally tolerated doses.
View Article and Find Full Text PDFCalcif Tissue Int
November 2024
Rare Disease Genomic Medicine Department, CHU Necker-Enfants Malades, INSERM UMR1163, Institut Imagine, Université Paris-Cité, Paris, France.
Osteoporosis is a skeletal disorder characterized by abnormal bone microarchitecture and low bone mineral density (BMD), responsible for an increased risk of fractures and skeletal fragility. It is a common pathology of the aging population. However, when osteoporosis occurs in children or young adults, it strongly suggests an underlying genetic etiology.
View Article and Find Full Text PDFJ Sleep Res
September 2024
Université Paris Cité, VIFASOM UPR 7330, Vigilance Fatigue Sommeil et Santé publique, Paris, France.
Cognitive and Behavioural Therapy for Insomnia (CBT-I) is the gold standard treatment for chronic insomnia, with one crucial step being the restriction of time spent in bed. This restriction often intensifies early afternoon sleepiness, leading to a natural gateway for a short recuperative nap, which might foster adherence to CBT-I over time. In practice, mental health professionals providing CBT-I lack consensus on whether or not to tolerate short naps during the CBT-I period for requesting patients.
View Article and Find Full Text PDFRetina
October 2024
Department of Ophthalmology, Reference Center for Rare Diseases, Pitié-Salpêtrière Hospital, Paris-Sorbonne University, Paris, France.
Purpose: To assess the long-term efficacy and safety of treatments for cystoid macular edema in birdshot retinochoroïditis.
Methods: Observational retrospective study of 142 HLA-A29-positive patients with cystoid macular edema; the main outcome was the optical coherence tomography intraretinal cysts resolution.
Results: During the mean follow-up of 75 months (12-178), 61.
CMAJ
August 2024
ICES (Campbell, Bell, Urbach, Paterson, Stukel, Gill, Baxter, Wilton, Gomez), Toronto, Ont.; Department of Ophthalmology (Campbell), Queen's University; Department of Ophthalmology (Campbell), Kingston Health Sciences Centre, Hotel Dieu Hospital site, Kingston, Ont.; Department of Ophthalmology (El-Defrawy), University of Toronto; Department of Ophthalmology (El-Defrawy), Kensington Eye Institute; Department of Medicine (Bell), University of Toronto; Institute of Health Policy, Management and Evaluation (Bell, Paterson, Stukel), University of Toronto; Department of Medicine (Bell), Sinai Health System; Department of Surgery (Urbach, Baxter, Gomez), Temerty Faculty of Medicine, University of Toronto, Toronto, Ont.; Department of Family Medicine, McMaster University, Hamilton, Ont.; Division of Geriatric Medicine (Gill), Queen's University; Division of Geriatric Medicine (Gill), Providence Care Hospital, Kingston, Ont.; Departments of Otolaryngology, Head and Neck Surgery and Surgical Oncology (Irish), University Health Network; Cancer Care Ontario (Irish); Li Ka Shing Knowledge Institute (Baxter, Gomez), St. Michael's Hospital, Toronto, Ont.; Melbourne School of Population and Global Health (Baxter), University of Melbourne, Melbourne, AU; Unity Health Toronto (Gomez), St. Michael's Hospital, Toronto, Ont.
Background: Public funding of cataract surgery provided in private, for-profit surgical centres increased to help mitigate surgical backlogs during the COVID-19 pandemic in Ontario, Canada. We sought to compare the socioeconomic status of patients who underwent cataract surgery in not-for-profit public hospitals with those who underwent this surgery in private for-profit surgical centres and to evaluate whether differences in access by socioeconomic status decreased after the infusion of public funding for private, for-profit centres.
Methods: We conducted a population-based study of all cataract operations in Ontario, Canada, between January 2017 and March 2022.
Chest
September 2024
Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, and Centre Hospitalier Universitaire Montpellier, Montpellier, France. Electronic address:
Background: To our knowledge, no large observational study has compared the incidence and risk factors for extubation failure within 48 h and during ICU stay in the same cohort of unselected critically ill patients with and without obesity.
Research Question: What are the incidence and risk factors of extubation failure in patients with and without obesity?
Study Design And Methods: In the prospective multicenter observational FREE-REA study in 26 ICUs, the primary objective was to compare the incidence of extubation failure within 48 h in patients with and without obesity. Secondary objectives were to describe and to identify the independent specific risk factors for extubation failure using first a logistic regression model and second a decision tree analysis.